Valentis Cancer Care Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
as on 16-12-2024
- Paid Up Capital ₹ 1.70 Cr
as on 16-12-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.56 Cr
as on 16-12-2024
- Satisfied Charges ₹ 20.90 Cr
as on 16-12-2024
- Revenue -2.25%
(FY 2021)
- Profit 14.47%
(FY 2021)
- Ebitda -20.78%
(FY 2021)
- Net Worth 32.86%
(FY 2021)
- Total Assets -14.59%
(FY 2021)
About Valentis Cancer Care Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.70 Cr.
The company currently has active open charges totaling ₹26.56 Cr. The company has closed loans amounting to ₹20.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Jain, Anita Jain, and Reshu Jain serve as directors at the Company.
- CIN/LLPIN
U85110UP2010PTC041765
- Company No.
041765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Valentis Cancer Care Hospital?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Jain  | Director | 23-Aug-2010 | Current |
| Anita Jain | Director | 23-Aug-2010 | Current |
| Reshu Jain | Director | 23-Aug-2010 | Current |
Financial of Valentis Cancer Care Hospital.
Valentis Cancer Care Hospital Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.25% decrease. The company also saw a substantial improvement in profitability, with a 14.47% increase in profit. The company's net worth Soared by an impressive increase of 32.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valentis Cancer Care Hospital?
In 2022, Valentis Cancer Care Hospital had a public holding of 42.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 20 Dec 2021 | ₹23.44 Cr | Open |
Indian Bank Creation Date: 14 Jul 2020 | ₹3.00 Cr | Open |
Allahabad Bank Creation Date: 20 Jan 2016 | ₹1.20 M | Open |
How Many Employees Work at Valentis Cancer Care Hospital?
Valentis Cancer Care Hospital has a workforce of 16 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valentis Cancer Care Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valentis Cancer Care Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
